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Summary: An evaluation of an enzyme immunoassay for the determination of theophylline in serum (EMIT, Syva
Corp.) is presented. The EMIT assay was fully mechanized by the use of an Eppendorf analyzer 5010. The precision
of this enzyme immunoassay was satisfactory (coefficients of variation from day to day ranged from 5-6%). The
EMIT assay proved to be specific, rapid and easy to perform. A comparison of the results obtained by EMIT and
ultraviolet spectrophotometry in a series of 100 patients showed a good correlation between both methods.
Überwachung der Theophyllinkonzentration im Serum mit einem vollmechanisierten Enzymimmunotest (EMIT)
Zusammenfassung: Es wird über die Erprobung eines Enzymimmunotests zur Bestimmung von Theophyllin im Serum
(EMIT, Syva Corp.) berichtet. Der EMIT-Test wurde mit Hilfe eines Eppendorf Enzymautomaten 5010 vollmechani-
siert. Die Präzision dieses Enzymimmunotests war zufriedenstellend (die Variationskoeffizienten von Tag zu Tag
lagen bei 5-6%). Der EMIT-Test erwies sich als spezifisch sowie rasch und einfach durchführbar. Ein Vergleich der
Ergebnisse, welche mit EMIT und einer UV-Methode bei einer Serie von 100 Patienten erhalten wurden, ergab eine
gute Übereinstimmung beider Verfahren.
Introduction
There is an increasing demand for rapid and reliable
assays for the determination of serum levels of drugs,
which have a narrow therapeutic range, and/or dangerous
side effects, and for which considerable differences of
pharmacokinetics between individuals are well
documented. Enzyme immunoassays have proved
useful for routine monitoring of serum levels of various
antiepileptic drugs and digoxin, and have recently
gained increasing importance (1,2).
Theophylline has been used for many years in the treat-
ment of asthma (3) and for treating apnoea in prema-
ture infants (4). It has been demonstrated recently that
the dosage of theophylline, based on ä widely used
body weight-derived formula (5), is unreliable and can
be dangerous (6, 7), as there is a wide variation in the
rate of metabolism of this compound (8). Patients with
hepatic disease such as liver cirrhosis, show a slow and
variable metabolism of theophylline, as about ninety
percent of this drug is metabolized in the liver (9).
Deaths from toxic theophylline concentrations have
been observed with patients receiving therapeutic doses
of the drug (10). The early detection of theophylline
overdosage by Clinical symptoms, however, may often
be difficult, because typical signs like tachycardia or
nausea are usually present in patients with respiratory
distress due to the underlying disease. Furthermore,
patients with toxic theophylline levels may develop
seizures without preceding adverse effects (10).
Monitoring of serum theophylline levels has therefore
been increasingly recommended in recent years (7,
11—15). Usually, serum levels of theophylline between
10 and 20 mg/1 provide substantial improvements in
pulmonary function with minimal toxicity (8). In
premature infants, serum concentrations of 6 to 11 mg/1
are necessary to control apnoeic spells (11).
The present study presents an evaluation of an homo-
geneous enzyme immunoassay for the determination of
theophylline (16), mechanized by means of an Eppen-
dorf analyzer 5010.
Material and Methods
Origin of specimens
Serum samples (n = 130) containing theophylline were obtained
from patients with obstructive lung disease. If theophylline was
administered by intravenous infusion, blood samples were drawn
from the cubital vein of the contralateral arm. During oral
maintenance therapy blood specimens were taken as recom-
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mended (7) either prior to the next dose or 2-4 hours after-
wards.
Materials
The reagents for the enzyme immunoassay (EMIT), ammonium
sulfate, chloroform, hexane, caffeine, xanthine, hypoxanthine,
xanthosine, uric acid and urea were obtained from E. Merck
(D-6100 Darmstadt), theophylline and paraxanthine from
Sigma (D-8021 Taufkirchen), theobromine from Synochem
(D-2000 Hamburg), l,3-dimethyl-xanthine-7-acetic 7-(/3-
dimethyl-aminoethoxy)-flavone from Voigt (D-6250 Limburg),
7-(0-hydroxyethyl)-theophylline and 7-dihydroxypropyl-theo-
phylline from Benechemie (D-8000 München), phenobarbitaj
from Krewel (D-5208 Eitorf), phenytoin from Nordmark
(D-2000 Hamburg), proxyphylline from Deutsche Pharmacia
(D-7800 Freiburg), salbutamol from Glaxo (D-2060 Bad "
Oldesloe), terbutaline from Astra Chemicals (D-2000 Wedel),
allopurinol from Ratiopharm (D-7902 Blaubeuren) and
sulfmethoxazole from Hoffmann-La Roche (D-7889 Grenzach-
Wyhlen).
Enzyme immunoassay (EMIT)
The original procedure of the EMIT theophylline assay was
fully mechanized by adapting this test to the Eppendorf
analyzer 5010 (Eppendorf, D-2000 Hamburg) in the same
way as previously described for the EMIT phenobarbital and
phenytoin assays (1).
Ultraviolet spectrophotometry
Ultraviolet spectrophotometry of theophylline in serum was
performed by a procedure discribed by Schwertner et al (17)
using a DMR 21 double beam recording spectrophotometer
(C. Zeiss, D-7082 Oberkochen).
Substrate determinations
Creatinine was measured in serum after tungstate precipation
of protein and a Fuller's earth adsorption procedure (18). Uric
acid was determined by the aldehyde dehydrogenase method
(19) (Human GmbH, D-6204 Taunusstein, cat. No H 1001)
using an Abbott Dichromatic analyzer ABA-100.
Results and Discussion
Precision
The coefficients of variation from day to day were
5-6% with EMIT, and 6-12% with ultraviolet spectro-
photometry (tab. 1). These precision data refer to mean
values of duplicate determinations.
Tab. 1. The precision from day to day of EMIT and an ultra-
violet spectrophotometric method for the determination
of theophylline in serum. Assays were performed in
duplicates on various days as indicated, and the mean
values were used for calculation of the precision.
Theo-
phyUinea)
(mg/1)
2.5
5.0
10.0
15.0
20.0
40.0
EMIT
X
(mg/1)
2.5
5.1
10.1
15.6
19.6
38.4
UV-Method
CVb)
(%)
5.7
5.9
5.9
5.1
5.1
5.7
nc)
20
20
20
26
20
18
X
(mg/1)
2.4
4.9
10.1
20.2
CV
<%)
12.5
6.1
5.9
7.9
n
9
7
' ' 11
5
a) Calibrators (Syva) and drug-free serum samples spiked with
theophylline^
) Mean value (x).with coefficient of variation
°) Number of days
Accuracy
The results for the recovery of theophylline by EMIT
are shown in table 2. The recovery of theophylline added
to drug-free pooled human serum ranged from 97-102%.
Furthermore the theophylline concentration was
measured by EMIT and ultraviolet spectrophotometry in
serum samples from 130 patients. However in nine of
these specimens the theophylline concentration could
not be determined by the ultraviolet method as the uv
spectra were distorted by extraneous overlapping peaks
due to interfering substances.
In a further 21 samples the theophylline concentration
could not be measured by EMIT as it was below 2.5 mg/1.
In three of these cases the uv method, however, gave
theophylline values between 3.6 and 8.0 mg/1 presumably
due to interference of proxyphylline and/or salbutamol.
The absorption maximum of proxyphylline (273 nm)
and salbutamol (276 nm) is very close to that of theo-
phylline (274 nm).
The least-squares regression analysis of the results
obtained with the remaining 100 serum samples showed
the slope of the line to be 1.01 (fig. 1). The value of the
Tab. 2. The recovery of theophylline by EMIT in spiked serum
samples. Determinations were performed in duplicate
on eight days (n = 16)
Theophylline
weighed in
(mg/1)
found
(mg/1)
Recovery
5.0
10.0
15.0
25.0
30.0
35.0
5.1
9.7
15.1
25.3
29.8
35.2
102
97
101
101
99
101
0.0 10.0 20.0 30.0 40.0
Theophylline (Ultraviolet spectrophotometry)[mg/l]
Fig. 1. Serum theophylline concentrations as measured by EMIT
and ultraviolet spectrophotometry (n = 100).
Slope: 1.01, intercept: - 0.38 mg/1,·correlation coefficient:
0.969.
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intercept was - 0.38 mg/1. Both methods correlated well
(coefficient of correlation: r = 0.969). The mean value
of the results of the ultraviolet spectrophotometric
method was 11.1 ± 6.3 mg/1 and that of the results
obtained by EMIT 10.9 ± 6.6 mg/1. The t-value was
1.35 (p> 0.05).
Deviations of more than 30% between the results
determined by EMIT and ultraviolet spectrophotometry
occurred with 8 out of these 100 samples. In five of
these cases the discrepancies were reproducible. With
four of these specimens the uv method yielded higher
results than EMIT. These samples were obtained from
patients who received salbutamol, 0-hydroxyethyl-
theophylline, trimethoprim and sulfamethoxazole in
addition to theophylline. These substances show absorp-
tion maxima between 257 and 276 nm, which are near
to that of theophylline. Therefore it appears, that these
compounds caused the deviations observed by an inter-
ference in the uv-method. With only one of these five
samples the uv-method yielded a lower result than
EMIT.
Our results are in agreement with the reported satis-
factory correlation of EMIT with ultraviolet spectro-
photometric methods (20—22), high pressure liquid
chromatography (21—23) and radioimmunoassay (22).
Tab. 3. Cross-reactivity of various substances in serum3) with
the EMIT theophylline assay.
Compound mg/lb)
Theophylline (1,3-dimethylxanthine) 2.5
Theobromine (3,7-dimethylxanthine) > 500
Paraxanthine (1,7-dimethylxanthine) > 500
Caffeine (1,3,7-trimethylxanthine) > 500
l,3-dimethyl-xanthine-7-acetic
7-(^-dimethyl-aminoethoxy)-flavone > 500
7-(0-Hydioxyethyl)-! ,3-dimethylxanthine > 5 00
Diprophylline
(7-(2,3-Dihydroxypropyl)-l,3-dimethylxanthine) > 500
Proxyphylline
(7-(2-Hydroxypropyl)-l,3-dimethylxanthine) > 500
Xanthine > 500
Hypoxanthine > 500
Xanthosine > 500
Uric acid > 500
Urea > 5000
Phenobarbital > 500
Phenytoin > 500
Terbutaline > 500
Salbutamol > 500
Allopurinol > 500
Sulphamethoxazole > 500
?) substances were added to drug-free pooled human serum.
) concentrations exerting an absorbance equivalent to
2.5 mg/1 tfieophylline.
Specificity
The specificity of the EMIT assay was tested by the
determination of the cross-reactivity of drugs structur-
ally related to theophylline and various other compounds.
The EMIT assay appeared to be highly specific, as none
of the substances tested (tab. 3) showed a noticeable
cross-reaction. According to the manufacturer's cross-
reactivity list (24) the major known metabolites of
theophylline (25), 1,3-dimethyluric acid, 3-methyl-
xanthine and 1-methyluric acid do not significantly
cross react in this assay. Of the two further possible
metabolites, 3-methyluric acid and 1-methykanthine,
only the latter showed a marked cross reaction at
concentrations above 10 mg/1 (24).
No positive results were obtained with serum samples
from patients (n = 20) with renal insufficiency, receiving
drugs other than theophylline (tab. 4).
Interferences
Bilirubin concentrations up to 600 μϊηοΐ/ΐ and haemo-
gjobiri concentrations up to 10 g/1 did not affect the
results of this assay. Triglyceride concentrations up to
4.0 mmpl/1 showed no interference.
Practicability and costs
The EMIT assay has the advantage that it can be easily
mechanized. Adaptations to various analyzers such as
the Abbott Bichromatic Analyzer (ABA 100) (21),
Rotochem II (26) and KA-150 Kinetic Analyser (20)
Tab. 4. Drugs showing no cross-reaction in the EMIT theo-
phylline assay. Serum samples (n = 20) were obtained
from patients with renal insufficiency, taking the drugs
listed_below (mean value of serum creatinine concentra-
tions χ = 464 μπιοΐ/ΐ (range 119-1233 μπιοΐ/ΐ) and of
uric acid concentrations χ = 434 μιηο1/1 (range
139-717 μηιοΐ/ΐ).
Compound
Furosemide
Clonidine
Dihydralazine
Allopurinol
Digoxin
0-A cetyldigoxin
0-Methyldigoxin
Cefalexine
Ampicillin
Gentamicin
Metoclopramide
Bromhexine
Prednisqne
Pheniiamine-p-amino-salicylate
Trade name
Lasix
Catapresan
Nepresol
Allopurinol
Lanicor
Novodigal mite
Lanitop
Oracef
Binotal
Refobacin
Paspertin
Bisolvon
Decortin
Avil
Dosage
(mg/day)
1000
1.2
100
600
0.25
0.1
0.1
3000
4000
40
30
24
10
150
have been reported. In contrast to other procedures,
such as ultraviolet spectrophotometry, the EMIT
method requires less time and sample volume. With our
fully mechanized modification of the EMIT assay only
10 μΐ of serum are necessary per theophylline determina-
tion, and about 30 patient samples can be analyzed
(duplicate determinations) within 90 minutes. A single
theophylline determination for emergency situations
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Tab. 5. Comparison of the costs of a quantitative determination of theophylline by an ultraviolet spectrophotometric method and
EMIT adapted to the Eppendorf analyzer 5010.
Costs
Technician time
Reagents, standards, control sera and
pertinent supplies
Total
DM
DM
DM
EMIT
n a)=l
12.00
77.28
89.28
n =10
1.50
19.35
20.85
n=30
0.80
13.39
14.19
UV-Spectrophotometry
n ^ l n=10 n=30
51.00
17.84
68.84
14.40
4.31
18.71
13.00
3.13
16.13
) n = number of specimens per series ) costs per minute technician time 0.60 DM (27).
takes about 40 minutes, as a new calibration curve has
to be prepared with every run. ·
The costs for a theophylline determination including
standards, control sera, reagents, pertinent supplies and
technician time are about 21 DM per EMIT test and
about 19 DM with the uv-method, for a series of 10
samples (duplicate determinations). A single theo-
phylline determination is much more expensive (tab. 5).
Conclusion
Compared with the ultraviolet spectrophotometric
method, the EMIT theophylline assay showed a
distinctly better specificity and practicability. Further-
more the EMIT assay could be easily mechanized and
proved to be rapid and reliable. The results of our
study showed the EMIT technique to be well suited
for monitoring serum theophylline levels.
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